A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Bacterial toxins (exotoxins, endotoxins, superantigens) are virulence factors that damage host tissues through enzymatic or immunomodulatory mechanisms. Exotoxins are secreted proteins; endotoxins (LPS) are outer-membrane components. Toxin function often determines clinical manifestations (e.g., Shiga toxin hemolytic uremia; cholera toxin secretory diarrhea).
Study structure-function relationships of A-B toxins (anthrax, diphtheria, cholera). Compare pathogenesis of different toxigenic and non-toxigenic strains.
Not all virulence is due to toxins; adhesins, invasion factors, and immune evasion are equally important. Toxin production often increases under nutrient stress or biofilm formation, not constantly.
From your study of lysogenic conversion, you know that bacteriophages can integrate into bacterial genomes and introduce new genes — including genes encoding toxins. This connection between viral infection and bacterial virulence is not coincidental: many of the most medically important bacterial toxins are encoded on prophages or other mobile genetic elements, meaning that a harmless bacterium can become a killer through a single genetic acquisition event. Understanding toxins requires grasping both their molecular mechanisms and how they connect to the clinical diseases they cause.
Bacterial toxins fall into two fundamentally different categories. Exotoxins are proteins actively secreted by living bacteria into their surroundings. They are potent, specific, and often enzymatic — a single molecule can catalyze thousands of reactions inside a host cell. The classic architecture is the A-B toxin: the B (binding) subunit attaches to a specific receptor on the host cell surface, and the A (active) subunit enters the cell to carry out enzymatic damage. Diphtheria toxin, for example, uses its B subunit to bind a growth factor receptor, then its A subunit ADP-ribosylates elongation factor 2, shutting down protein synthesis and killing the cell. Cholera toxin binds GM1 gangliosides on intestinal epithelial cells, and its A subunit permanently activates adenylyl cyclase, causing massive chloride and water secretion — the profuse watery diarrhea that defines cholera. Endotoxin is entirely different: it is not a secreted protein but a structural component of the gram-negative outer membrane — lipopolysaccharide (LPS) — released when bacteria lyse. LPS triggers a systemic inflammatory response by activating TLR4 on macrophages, and in large quantities produces septic shock through massive cytokine release.
A third category, superantigens, works by a unique mechanism that exploits your knowledge of T cell activation. Normal antigens are processed and presented on MHC to activate a small fraction of T cells with matching TCRs. Superantigens like staphylococcal toxic shock syndrome toxin (TSST-1) bypass this specificity entirely: they crosslink MHC class II molecules on antigen-presenting cells directly to the Vβ region of TCRs, activating up to 20% of all T cells simultaneously. The resulting cytokine storm — massive release of IL-2, TNF-α, and IFN-γ — produces fever, hypotension, organ failure, and the clinical syndrome of toxic shock.
The clinical significance of toxins extends beyond acute disease. Toxin neutralization is the basis for several medical interventions: antitoxins (antibodies against the toxin) can treat diphtheria and botulism even after infection is established, and toxoid vaccines (chemically inactivated toxins that retain immunogenicity) protect against diphtheria and tetanus. The fact that neutralizing the toxin alone can prevent disease — even without killing the bacterium — underscores that for many toxigenic infections, it is the toxin, not the bacterium itself, that causes the pathology.